These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 8642312)

  • 1. Anergic T cells are defective in both jun NH2-terminal kinase and mitogen-activated protein kinase signaling pathways.
    DeSilva DR; Feeser WS; Tancula EJ; Scherle PA
    J Exp Med; 1996 May; 183(5):2017-23. PubMed ID: 8642312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The p38 mitogen-activated protein kinase pathway in activated and anergic Th1 cells.
    DeSilva DR; Jones EA; Feeser WS; Manos EJ; Scherle PA
    Cell Immunol; 1997 Sep; 180(2):116-23. PubMed ID: 9341741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blocked signal transduction to the ERK and JNK protein kinases in anergic CD4+ T cells.
    Li W; Whaley CD; Mondino A; Mueller DL
    Science; 1996 Mar; 271(5253):1272-6. PubMed ID: 8638107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reductions in the activation of ERK and JNK are associated with decreased IL-2 production in T cells from elderly humans stimulated by the TCR/CD3 complex and costimulatory signals.
    Liu B; Carle KW; Whisler RL
    Cell Immunol; 1997 Dec; 182(2):79-88. PubMed ID: 9514699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blocked Ras activation in anergic CD4+ T cells.
    Fields PE; Gajewski TF; Fitch FW
    Science; 1996 Mar; 271(5253):1276-8. PubMed ID: 8638108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of T lymphocyte activation by cAMP is associated with down-regulation of two parallel mitogen-activated protein kinase pathways, the extracellular signal-related kinase and c-Jun N-terminal kinase.
    Tamir A; Granot Y; Isakov N
    J Immunol; 1996 Aug; 157(4):1514-22. PubMed ID: 8759733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p38 mitogen-activated protein kinase mediates signal integration of TCR/CD28 costimulation in primary murine T cells.
    Zhang J; Salojin KV; Gao JX; Cameron MJ; Bergerot I; Delovitch TL
    J Immunol; 1999 Apr; 162(7):3819-29. PubMed ID: 10201899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Signaling alterations in activation-induced nonresponsive CD8 T cells.
    Tham EL; Mescher MF
    J Immunol; 2001 Aug; 167(4):2040-8. PubMed ID: 11489986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of cytokine production and AP-1 transcriptional activity in T cells by thalidomide-related immunomodulatory drugs.
    Schafer PH; Gandhi AK; Loveland MA; Chen RS; Man HW; Schnetkamp PP; Wolbring G; Govinda S; Corral LG; Payvandi F; Muller GW; Stirling DI
    J Pharmacol Exp Ther; 2003 Jun; 305(3):1222-32. PubMed ID: 12649301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activated Ki-Ras suppresses 12-O-tetradecanoylphorbol-13-acetate-induced activation of the c-Jun NH2-terminal kinase pathway in human colon cancer cells.
    Okumura K; Shirasawa S; Nishioka M; Sasazuki T
    Cancer Res; 1999 May; 59(10):2445-50. PubMed ID: 10344756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. JNK (c-Jun NH2-terminal kinase) is a target for antioxidants in T lymphocytes.
    Gómez del Arco P; Martínez-Martínez S; Calvo V; Armesilla AL; Redondo JM
    J Biol Chem; 1996 Oct; 271(42):26335-40. PubMed ID: 8824287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Constitutive active p21ras enhances primary T cell responsiveness to Ca2+ signals without interfering with the induction of clonal anergy.
    Crespi D; Massa S; Basso V; Colombetti S; Mueller DL; Mondino A
    Eur J Immunol; 2002 Sep; 32(9):2500-9. PubMed ID: 12207334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo anergized CD4+ T cells have defective expression and function of the activating protein-1 transcription factor.
    Sundstedt A; Dohlsten M
    J Immunol; 1998 Dec; 161(11):5930-6. PubMed ID: 9834073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The GABP-responsive element of the interleukin-2 enhancer is regulated by JNK/SAPK-activating pathways in T lymphocytes.
    Hoffmeyer A; Avots A; Flory E; Weber CK; Serfling E; Rapp UR
    J Biol Chem; 1998 Apr; 273(17):10112-9. PubMed ID: 9553058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Costimulation requirement for AP-1 and NF-kappa B transcription factor activation in T cells.
    Jung S; Yaron A; Alkalay I; Hatzubai A; Avraham A; Ben-Neriah Y
    Ann N Y Acad Sci; 1995 Sep; 766():245-52. PubMed ID: 7486667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein kinase Ctheta, a selective upstream regulator of JNK/SAPK and IL-2 promoter activation in Jurkat T cells.
    Ghaffari-Tabrizi N; Bauer B; Villunger A; Baier-Bitterlich G; Altman A; Utermann G; Uberall F; Baier G
    Eur J Immunol; 1999 Jan; 29(1):132-42. PubMed ID: 9933094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age-related reductions in the activation of mitogen-activated protein kinases p44mapk/ERK1 and p42mapk/ERK2 in human T cells stimulated via ligation of the T cell receptor complex.
    Whisler RL; Newhouse YG; Bagenstose SE
    Cell Immunol; 1996 Mar; 168(2):201-10. PubMed ID: 8640866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired CD28-mediated interleukin 2 production and proliferation in stress kinase SAPK/ERK1 kinase (SEK1)/mitogen-activated protein kinase kinase 4 (MKK4)-deficient T lymphocytes.
    Nishina H; Bachmann M; Oliveira-dos-Santos AJ; Kozieradzki I; Fischer KD; Odermatt B; Wakeham A; Shahinian A; Takimoto H; Bernstein A; Mak TW; Woodgett JR; Ohashi PS; Penninger JM
    J Exp Med; 1997 Sep; 186(6):941-53. PubMed ID: 9294148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stabilization of interleukin-2 mRNA by the c-Jun NH2-terminal kinase pathway.
    Chen CY; Del Gatto-Konczak F; Wu Z; Karin M
    Science; 1998 Jun; 280(5371):1945-9. PubMed ID: 9632395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulation of urokinase-type plasminogen activator receptor expression by PMA requires JNK1-dependent and -independent signaling modules.
    Gum R; Juarez J; Allgayer H; Mazar A; Wang Y; Boyd D
    Oncogene; 1998 Jul; 17(2):213-25. PubMed ID: 9674706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.